Could melatonin be used in COVID‐19 patients with laryngopharyngeal reflux disease?

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journalLetterpeer-review

Abstract

The study by Jiang et al. [1] to determine the impact of laryngopharyngeal reflux disease (LPRD) on the clinical outcomes in hospitalized patients with novel coronavirus disease 2019 (COVID‐19) is first of its kind study in the literature. While available studies have mostly focused on the effect of cardiovascular comorbidities, the authors' work raises the concurrent gastrointestinal related issues in patients with COVID‐19.
Original languageEnglish
Pages (from-to)92-93
Number of pages2
JournalJournal of Medical Virology
Volume93
Issue number1
Early online date10 Jun 2020
DOIs
Publication statusPublished - 1 Jan 2021

Fingerprint

Dive into the research topics of 'Could melatonin be used in COVID‐19 patients with laryngopharyngeal reflux disease?'. Together they form a unique fingerprint.

Cite this